Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Why Shares of STAAR Surgical Company Are Soaring Today

By Timothy Green - May 3, 2018 at 1:07PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company's lenses enjoyed a big sales boost during the first quarter.

What happened

Shares of STAAR Surgical Company ( STAA -2.95% ) surged Thursday following a first-quarter report that handily beat analyst expectations. The manufacturer of implantable lenses and companion delivery systems managed to grow revenue by 33%, leading investors to drive the stock about 28% higher by 12:20 p.m. EDT.

So what

STAAR reported first-quarter revenue of $27.1 million, up 33% year over year and about $4 million higher than the average analyst estimate. Sales of Implantable Collamer Lens, or ICL, products surged 39%, with units up 41% from the prior-year period.

A rising chart on a screen.

Image source: Getty Images.

Non-GAAP earnings per share came in at $0.04, up from a loss of $0.04 in the prior-year period and $0.08 higher than analysts were expecting. Higher revenue and a 10-basis point improvement in gross margin more than offset an increase in operating expenses.

"The record sales STAAR generated in the first quarter represents a meaningful acceleration from the emerging growth we saw in the second half of last year and illustrates our team's initial progress toward achieving the strong growth priorities of the recently announced 2018-2020 strategic plan," said STAAR President and CEO Caren Mason.

Now what

Because of STAAR's strong first-quarter sales, the company boosted its fiscal year 2018 sales target. The company now expects to grow full-year sales by around 20% from 2017, up from a previous outlook calling for low double-digit growth.

An across-the-board beat and a boost to guidance gave investors plenty of reasons to push up the stock Thursday.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

STAAR Surgical Company Stock Quote
STAAR Surgical Company
$89.37 (-2.95%) $-2.72

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/04/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.